Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kim Mallard

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Plos One|September 3, 2010
Changes in Mycobacterium tuberculosis genotype families over 20 years in a population-based study in Northern MalawiJudith R Glynn, Saad Alghamdi, Kim Mallard, et al.
International Journal of Mycobacteriology|December 15, 2015
Characterization of genomic variations in SNPs of PE_PGRS genes reveals deletions and insertions in extensively drug resistant (XDR) M. tuberculosis strains from PakistanAkbar Kanji, Zahra Hasan, Asho Ali, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|April 14, 2009
HIV and the risk of tuberculosis due to recent transmission over 12 years in Karonga District, MalawiRein M G J Houben, Amelia C Crampin, Kim Mallard, et al.
Annals of Clinical Microbiology and Antimicrobials|January 11, 2007
Low-cost rapid detection of rifampicin resistant tuberculosis using bacteriophage in Kampala, UgandaHamidou Traore, Sam Ogwang, Kim Mallard, et al.
BMC Genomics|August 16, 2018
Identifying mixed Mycobacterium tuberculosis infections from whole genome sequence dataBenjamin Sobkowiak, Judith R Glynn, Rein M G J Houben, et al.
BMC Genomics|November 20, 2014
Unraveling Mycobacterium tuberculosis genomic diversity and evolution in Lisbon, Portugal, a highly drug resistant settingJoão Perdigão, Hugo Silva, Diana Machado, et al.
The Journal of Infectious Diseases|October 23, 2014
Recurrence due to relapse or reinfection with Mycobacterium tuberculosis: a whole-genome sequencing approach in a large, population-based cohort with a high HIV infection prevalence and active follow-upJosé Afonso Guerra-Assunção, Rein M G J Houben, Amelia C Crampin, et al.
BMJ Open|November 22, 2023
Evaluating niraparib versus active symptom control in patients with previously treated mesothelioma (NERO): a study protocol for a multicentre, randomised, two-arm, open-label phase II trial in UK secondary care centresDean Fennell, Daniel Griffiths, Zina Eminton, et al.
BMC Medicine|March 24, 2016
Mycobacterium tuberculosis whole genome sequencing and protein structure modelling provides insights into anti-tuberculosis drug resistanceJody Phelan, Francesc Coll, Ruth McNerney, et al.
Plos One|December 19, 2013
Elucidating emergence and transmission of multidrug-resistant tuberculosis in treatment experienced patients by whole genome sequencingTaane G Clark, Kim Mallard, Francesc Coll, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Plos One|September 3, 2010
Changes in Mycobacterium tuberculosis genotype families over 20 years in a population-based study in Northern MalawiJudith R Glynn, Saad Alghamdi, Kim Mallard, et al.
International Journal of Mycobacteriology|December 15, 2015
Characterization of genomic variations in SNPs of PE_PGRS genes reveals deletions and insertions in extensively drug resistant (XDR) M. tuberculosis strains from PakistanAkbar Kanji, Zahra Hasan, Asho Ali, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|April 14, 2009
HIV and the risk of tuberculosis due to recent transmission over 12 years in Karonga District, MalawiRein M G J Houben, Amelia C Crampin, Kim Mallard, et al.
Annals of Clinical Microbiology and Antimicrobials|January 11, 2007
Low-cost rapid detection of rifampicin resistant tuberculosis using bacteriophage in Kampala, UgandaHamidou Traore, Sam Ogwang, Kim Mallard, et al.
BMC Genomics|August 16, 2018
Identifying mixed Mycobacterium tuberculosis infections from whole genome sequence dataBenjamin Sobkowiak, Judith R Glynn, Rein M G J Houben, et al.
BMC Genomics|November 20, 2014
Unraveling Mycobacterium tuberculosis genomic diversity and evolution in Lisbon, Portugal, a highly drug resistant settingJoão Perdigão, Hugo Silva, Diana Machado, et al.
The Journal of Infectious Diseases|October 23, 2014
Recurrence due to relapse or reinfection with Mycobacterium tuberculosis: a whole-genome sequencing approach in a large, population-based cohort with a high HIV infection prevalence and active follow-upJosé Afonso Guerra-Assunção, Rein M G J Houben, Amelia C Crampin, et al.
BMJ Open|November 22, 2023
Evaluating niraparib versus active symptom control in patients with previously treated mesothelioma (NERO): a study protocol for a multicentre, randomised, two-arm, open-label phase II trial in UK secondary care centresDean Fennell, Daniel Griffiths, Zina Eminton, et al.
BMC Medicine|March 24, 2016
Mycobacterium tuberculosis whole genome sequencing and protein structure modelling provides insights into anti-tuberculosis drug resistanceJody Phelan, Francesc Coll, Ruth McNerney, et al.
Plos One|December 19, 2013
Elucidating emergence and transmission of multidrug-resistant tuberculosis in treatment experienced patients by whole genome sequencingTaane G Clark, Kim Mallard, Francesc Coll, et al.
Pageof 3